Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Erasca, Inc. | 2,000,000 | reported | 29 Jan 2026 | tx 14+11,223,759−2,000,006 |
| HALOZYME THERAPEUTICS, INC. | 102,478 | reported | 04 Feb 2010 | tx 234+865,106−950,503 |
| Boundless Bio, Inc. | 24,000 | reported | 23 Jun 2025 | tx 7+569,103−525,274 |
| Maze Therapeutics, Inc. | 18,000 | reported | 22 Sept 2025 | tx 8+340,746−2,600,788 |
| Ignyta, Inc. | 0 | reported | 08 Feb 2018 | tx 22+520,333−4,202,000 |
Average stock performance after each discretionary buy, measured at 1, 3 and 6 months. 7 buys in history.
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 29 Jan 2026 | GRANT_AWARD | Erasca, Inc. | 2,000,000 | 0.00 USD | deriv |
| 22 Sept 2025 | GRANT_AWARD | Maze Therapeutics, Inc. | 18,000 | 0.00 USD | deriv |
| 23 Jun 2025 | GRANT_AWARD | Boundless Bio, Inc. | 24,000 | 0.00 USD | deriv |
| 03 Feb 2025 | GRANT_AWARD | Erasca, Inc. | 2,500,000 | 0.00 USD | deriv |
| 03 Feb 2025 | CONVERSION | Maze Therapeutics, Inc. | 37,724 | — | |
| 03 Feb 2025 | CONVERSION | Maze Therapeutics, Inc. | 270,232 | — | |
| 03 Feb 2025 | CONVERSION | Maze Therapeutics, Inc. | 363,703 | — | deriv |
| 09 Dec 2024 | OTHER | Maze Therapeutics, Inc. | 5,704 | — | deriv |
| 09 Dec 2024 | GRANT_AWARD | Maze Therapeutics, Inc. | 5,704 | — | deriv |
| 03 Feb 2025 | CONVERSION | Maze Therapeutics, Inc. | 2,231,381 | — | deriv |
| 09 Dec 2024 | GRANT_AWARD | Maze Therapeutics, Inc. | 9,086 | 0.00 USD | deriv |
| 20 Jun 2024 | GRANT_AWARD | Erasca, Inc. | 632,759 | 0.00 USD | deriv |
| 20 Jun 2024 | GRANT_AWARD | Boundless Bio, Inc. | 6,610 | 0.00 USD | deriv |
| 02 Apr 2024 | CONVERSION | Boundless Bio, Inc. | 525,274 | — | |
| 02 Apr 2024 | CONVERSION | Boundless Bio, Inc. | 7,326 | — | deriv |
| 02 Apr 2024 | CONVERSION | Boundless Bio, Inc. | 512,820 | — | deriv |
| 02 Apr 2024 | CONVERSION | Boundless Bio, Inc. | 5,128 | — | deriv |
| 27 Mar 2024 | GRANT_AWARD | Boundless Bio, Inc. | 13,219 | 0.00 USD | deriv |
| 05 Feb 2024 | GRANT_AWARD | Erasca, Inc. | 1,500,000 | 0.00 USD | deriv |
| 06 Dec 2023 | PURCHASE | Erasca, Inc. | 278,150 | 1.72 USD | |
| 05 Dec 2023 | PURCHASE | Erasca, Inc. | 721,850 | 1.69 USD | |
| 05 Oct 2023 | PURCHASE | Erasca, Inc. | 1,000,000 | 2.03 USD | |
| 08 Jun 2023 | PURCHASE | Erasca, Inc. | 100,000 | 2.75 USD | |
| 28 Mar 2023 | PURCHASE | Erasca, Inc. | 100,000 | 2.84 USD | |
| 30 Nov 2022 | GIFT | Erasca, Inc. | 2,000,006 | 0.00 USD |
1 purchase reported after at least 12 months of silence — most recent on 14 Dec 2022.